WeWork Working Toward IPO, Valisure Says Carcinogen Found in Zantac, Investing in Global Disruption
Bloomberg Businessweek
WeWork Working Toward IPO, Valisure Says Carcinogen Found in Zantac, Investing in Global Disruption
00:00 / 33:34